Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Invested Capital (2016 - 2025)

Historic Invested Capital for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $151.1 million.

  • OptimizeRx's Invested Capital rose 2969.82% to $151.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.1 million, marking a year-over-year increase of 2969.82%. This contributed to the annual value of $151.3 million for FY2024, which is 822.3% down from last year.
  • As of Q3 2025, OptimizeRx's Invested Capital stood at $151.1 million, which was up 2969.82% from $148.6 million recorded in Q2 2025.
  • OptimizeRx's Invested Capital's 5-year high stood at $164.8 million during Q4 2023, with a 5-year trough of $115.8 million in Q2 2023.
  • For the 5-year period, OptimizeRx's Invested Capital averaged around $132.7 million, with its median value being $126.8 million (2021).
  • Per our database at Business Quant, OptimizeRx's Invested Capital surged by 18658.96% in 2021 and then tumbled by 1775.51% in 2023.
  • Over the past 5 years, OptimizeRx's Invested Capital (Quarter) stood at $131.4 million in 2021, then fell by 4.01% to $126.1 million in 2022, then soared by 30.71% to $164.8 million in 2023, then fell by 8.22% to $151.3 million in 2024, then decreased by 0.16% to $151.1 million in 2025.
  • Its Invested Capital stands at $151.1 million for Q3 2025, versus $148.6 million for Q2 2025 and $150.1 million for Q1 2025.